首页|血塞通注射液联合常规药物治疗急性脑梗死患者的效果

血塞通注射液联合常规药物治疗急性脑梗死患者的效果

扫码查看
目的:观察血塞通注射液联合常规药物治疗急性脑梗死患者的效果.方法:回顾性分析 2020 年 2 月至 2021 年 2 月该院收治的 80 例急性脑梗死患者的临床资料,按照治疗方法不同将其分为对照组和研究组各 40 例.对照组予以常规药物(依达拉奉+倍他司汀)治疗,研究组在对照组基础上联合血塞通注射液治疗,两组均连续治疗 14 d.比较两组临床疗效,治疗前后神经功能缺损[美国国立卫生院卒中量表(NIHSS)]评分、椎基底动脉(左椎动脉、右椎动脉、基底动脉)血流速度、炎性指标[白细胞介素-1β(IL-1β)、肿瘤坏死因子-α(TNF-α)]水平、认知功能[蒙特利尔认知评估量表(MoCA)]评分和日常生活活动能力[Barthel指数(BI)]评分.结果:研究组治疗总有效率为 92.50%(37/40),高于对照组的 75.00%(30/40),差异有统计学意义(P<0.05);治疗后,研究组NIHSS评分低于对照组,差异有统计学意义(P<0.05);治疗后,研究组左椎动脉、右椎动脉、基底动脉血流速度均高于对照组,差异有统计学意义(P<0.05);治疗后,研究组IL-1β、TNF-α水平均低于对照组,差异有统计学意义(P<0.05);治疗后,研究组MoCA、BI评分均高于对照组,差异有统计学意义(P<0.05).结论:血塞通注射液联合常规药物治疗急性脑梗死患者可提高治疗总有效率和认知功能、日常生活活动能力评分,降低神经功能缺损评分和炎性指标水平,改善椎基底动脉血流速度,效果优于单纯常规药物治疗.
Effects of Xuesaitong injection combined with conventional drugs in treatment of patients with acute cerebral infarction
Objective:To observe effects of Xuesaitong injection combined with conventional drugs in treatment of patients with acute cerebral infarction.Methods:The clinical data of 80 patients with acute cerebral infarction admitted to this hospital from February 2020 to February 2021 were retrospectively analyzed.According to different treatment methods,they were divided into control group and study group,40 cases in each group.The control group was treated with conventional drugs(Edaravone+Betahistine),while the study group was treated with Xuesaitong injection on the basis of that of the control group.Both groups were treated for 14 d.The clinical efficacy,the neurological deficit[National Institutes of Health stroke scale(NIHSS)]score,the vertebrobasilar artery(left vertebral artery,right vertebral artery,basilar artery)blood flow velocities,the inflammatory index[interleukin-1β(IL-1β),tumor necrosis factor-α(TNF-α)]levels,the cognitive function[Montreal Cognitive Assessment Scale(MoCA)]score,and the activities of daily living[Barthel Index(BI)]score were compared between the two groups before and after the treatment.Results:The total effective rate of the study group was 92.50%(37/40),which was higher than 75.00%(30/40)of the control group,and the difference was statistically significant(P<0.05).After the treatment,the NIHSS score of the study group was lower than that of the control group,and the difference was statistically significant(P<0.05).After the treatment,the blood flow velocities of left vertebral artery,right vertebral artery and basilar artery in the study group were higher than that in the control group,and the differences were statistically significant(P<0.05).After the treatment,the levels of IL-1β and TNF-α in the study group were lower than those in the control group,and the differences were statistically significant(P<0.05).Further,after the treatment,the scores of MoCA and BI in the study group were higher than those in the control group,and the differences were statistically significant(P<0.05).Conclusions:Xuesaitong injection combined with conventional drugs in the treatment of the patients with acute cerebral infarction can improve the total effective rate,the cognitive function and the activity of daily living scores,reduce the neurological deficit scores and inflammatory index levels,and improve the blood flow velocity of vertebrobasilar artery.Moreover,it is superior to single conventional drug therapy.

Acute cerebral infarctionXuesaitongEdaravoneBetahistineVertebrobasilar arteryBlood flow velocityNeurological deficit

曾武成、曹运红

展开 >

惠东县多祝镇增光卫生院内科,广东 惠州 516300

急性脑梗死 血塞通 依达拉奉 倍他司汀 椎基底动脉 血流速度 神经功能缺损

2024

中国民康医学
中国社会工作协会

中国民康医学

影响因子:0.649
ISSN:1672-0369
年,卷(期):2024.36(12)
  • 12